Septerna (SEPN) Change in Account Payables (2023 - 2026)
Septerna's (SEPN) quarterly Change in Account Payables came in at -$2.3 million in Q1 2026, down 294.1% year-on-year from $1.2 million in Q1 2025, and down 137.91% quarter-over-quarter from $6.1 million in Q4 2025.
Septerna (SEPN) Change in Account Payables (2023 - 2026) Analysis & Trends
Septerna's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 294.1% year-over-year to -$2.3 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 51.8% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 813.28% from the prior year.
- Change in Account Payables slipped to -$2.3 million in Q1 2026 per SEPN's latest filing, from $6.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.1 million in Q4 2025 and bottomed at -$2.9 million in Q3 2025.
- The 4-year median for Change in Account Payables is $167500.0 (2023), against an average of $550200.0.
- Across the five-year window, Change in Account Payables slumped 454.81% in 2024 and jumped 1214.21% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $478000.0 in 2023, then slumped by 454.81% to -$1.7 million in 2024, then jumped by 458.08% to $6.1 million in 2025, then plunged by 137.91% to -$2.3 million in 2026.
- Per Business Quant, the three latest SEPN Change in Account Payables figures stand at -$2.3 million (Q1 2026), $6.1 million (Q4 2025), and -$2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.30 Mn |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | -2.85 Mn |
| Sep 30, 2025 | -2.85 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | -197,000.00 |
| Jun 30, 2024 | -197,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Dec 31, 2023 | 478,000.00 |
| Dec 31, 2023 | 478,000.00 |